Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q4 2021 (Next →)

Filing Date: Feb 14, 2022

Total Value: $350M (100.0% shares, 0.0% debt)

Holdings (24)

MIRATI THERAPEUTICS INC 10.9%
Value $38.16M Shares 260,115 Est. Cost $146.69 Unrealized
ASND ASCENDIS PHARMA A/S 8.4%
Value $29.35M Shares 218,158 Est. Cost $134.53 Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 7.2%
Value $25.25M Shares 300,434 Est. Cost $77.38 Unrealized 0.0%
VRDN VIRIDIAN THERAPEUTICS INC 6.8%
Value $23.9M Shares 1,209,051 Est. Cost $18.63 Unrealized 0.0%
ARENA PHARMACEUTICALS INC 6.7%
Value $23.4M Shares 251,777 Est. Cost $92.94 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 6.5%
Value $22.84M Shares 780,480 Est. Cost $29.27 Unrealized
ARVN ARVINAS INC 6.3%
Value $22.06M Shares 268,519 Est. Cost $81.37 Unrealized 0.0%
LEGN LEGEND BIOTECH CORP 5.1%
Value $17.99M Shares 385,967 Est. Cost $46.61 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.6%
Value $16.11M Shares 844,005 Est. Cost $22.02 Unrealized 0.0%
SEAGEN INC 4.4%
Value $15.57M Shares 100,687 Est. Cost $154.60 Unrealized
ARGX ARGENX SE 4.2%
Value $14.72M Shares 42,050 Est. Cost $350.18 Unrealized
IVERIC BIO INC 3.9%
Value $13.64M Shares 815,581 Est. Cost $16.72 Unrealized
INSM INSMED INC 3.1%
Value $10.74M Shares 394,358 Est. Cost $28.59 Unrealized 0.0%
SIERRA ONCOLOGY INC 2.9%
Value $10.32M Shares 474,945 Est. Cost $21.74 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 2.8%
Value $9.918M Shares 453,091 Est. Cost $18.48 Unrealized 0.0%
GLPG GALAPAGOS NV 2.6%
Value $9.252M Shares 167,824 Est. Cost $55.13 Unrealized
CCCC C4 THERAPEUTICS INC 2.4%
Value $8.332M Shares 258,746 Est. Cost $39.55 Unrealized 0.0%
KYMR KYMERA THERAPEUTICS INC 2.3%
Value $7.991M Shares 125,858 Est. Cost $58.25 Unrealized 0.0%
VOR BIOPHARMA INC 2.1%
Value $7.313M Shares 629,342 Est. Cost $11.62 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 1.6%
Value $5.646M Shares 75,507 Est. Cost $78.47 Unrealized 0.0%
OYSTER PT PHARMA INC 1.6%
Value $5.555M Shares 304,238 Est. Cost $18.26 Unrealized
IMCR IMMUNOCORE HLDGS PLC 1.3%
Value $4.597M Shares 134,249 Est. Cost $34.24 Unrealized
ESPR ESPERION THERAPEUTICS INC NE 1.2%
Value $4.196M Shares 839,257 Est. Cost $8.01 Unrealized 0.0%
GRACELL BIOTECHNOLOGIES INC 0.9%
Value $3.294M Shares 545,388 Est. Cost $6.04 Unrealized